Cholinesterase inhibitors in the treatment of Alzheimer's disease: a comparison of tolerability and pharmacology.

@article{Nordberg1998CholinesteraseII,
  title={Cholinesterase inhibitors in the treatment of Alzheimer's disease: a comparison of tolerability and pharmacology.},
  author={A. Nordberg and Anna Svensson},
  journal={Drug safety},
  year={1998},
  volume={19 6},
  pages={
          465-80
        }
}
Cholinesterase inhibitors are currently the most established treatment strategy in Alzheimer's disease. The treatment effect appears mainly to be symptomatic. Effects on progression of the disease following long term treatment, and possible neuroprotective effects, have been investigated. Delay until nursing home placement has been reported. Three cholinesterase inhibitors, tacrine, donepezil and rivastigmine, are in clinical use. Other cholinesterase inhibitors, such as galantamine… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 71 extracted citations

Small molecule blockers of the Alzheimer A calcium channel potently protect neurons from A cytotoxicity

Juan Carlos Diaza, Olga Simakovaa, Kenneth A. Jacobsonb, Nelson Arispea, Harvey B. Pollarda
2009
View 4 Excerpts
Highly Influenced

Current pharmacologic options for patients with Alzheimer's disease

Annals of general hospital psychiatry • 2003
View 5 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…